Xtant Medical Holdings Inc [AMEX: XTNT] traded at a high on Wednesday, posting a 3.86 gain after which it closed the day’ session at $0.62.
The results of the trading session contributed to over 6865371 shares changing hands. Over the past one week, the price volatility of Xtant Medical Holdings Inc stands at 11.98% while the volatility over the past one month is 11.20%.
The market cap for XTNT stock reached $86.32 million, with 139.08 million shares outstanding and 115.47 million shares in the current float. Compared to the average trading volume of 104.45K shares, XTNT reached a trading volume of 6865371 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Xtant Medical Holdings Inc [XTNT]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for XTNT shares is $1.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on XTNT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
BTIG Research have made an estimate for Xtant Medical Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 05, 2023. While these analysts kept the previous recommendation, Maxim Group raised their target price from $10 to $6. The new note on the price target was released on November 15, 2018, representing the official price target for Xtant Medical Holdings Inc stock. Previously, the target price had yet another drop from $18 to $10, while Maxim Group kept a Buy rating on XTNT stock.
The Average True Range (ATR) for Xtant Medical Holdings Inc is set at 0.06, with the Price to Sales ratio for XTNT stock in the period of the last 12 months amounting to 0.71. The Price to Book ratio for the last quarter was 1.96, with the Price to Cash per share for the same quarter was set at 0.04.
How has XTNT stock performed recently?
Xtant Medical Holdings Inc [XTNT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 19.54. With this latest performance, XTNT shares gained by 54.90% in over the last four-week period, additionally plugging by 17.91% over the last 6 months – not to mention a drop of -23.53% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for XTNT stock in for the last two-week period is set at 68.21, with the RSI for the last a single of trading hit 74.32, and the three-weeks RSI is set at 63.63 for Xtant Medical Holdings Inc [XTNT]. The present Moving Average for the last 50 days of trading for this stock 0.4759, while it was recorded at 0.5556 for the last single week of trading, and 0.5306 for the last 200 days.
Xtant Medical Holdings Inc [XTNT]: Deeper insight into the fundamentals
Xtant Medical Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.03 and a Current Ratio set at 2.34.
Insider trade positions for Xtant Medical Holdings Inc [XTNT]
There are presently around $57.75%, or 67.69%% of XTNT stock, in the hands of institutional investors. The top three institutional holders of XTNT stocks are: ORBIMED ADVISORS LLC with ownership of 73.11 million shares, which is approximately 56.1256%. ALTIUM CAPITAL MANAGEMENT LP, holding 7.42 million shares of the stock with an approximate value of $$4.67 million in XTNT stocks shares; and ALTIUM CAPITAL MANAGEMENT LP, currently with $$2.26 million in XTNT stock with ownership which is approximately 2.7481%.
